Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
23.91
+0.19 (0.80%)
Nov 21, 2024, 11:56 AM EST - Market open
Xencor Market Cap
Xencor has a market cap or net worth of $1.67 billion as of November 21, 2024. Its market cap has increased by 50.03% in one year.
Market Cap
1.67B
Enterprise Value
910.37M
1-Year Change
50.03%
Ranking
Category
Stock Price
$23.91
Market Cap Chart
Since December 3, 2013, Xencor's market cap has increased from $245.40M to $1.67B, an increase of 581.85%. That is a compound annual growth rate of 19.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 1.65B | 27.96% |
| Dec 29, 2023 | 1.29B | -17.18% |
| Dec 30, 2022 | 1.56B | -33.50% |
| Dec 31, 2021 | 2.35B | -6.40% |
| Dec 31, 2020 | 2.51B | 28.51% |
| Dec 31, 2019 | 1.95B | -4.07% |
| Dec 31, 2018 | 2.03B | 97.53% |
| Dec 29, 2017 | 1.03B | -4.93% |
| Dec 30, 2016 | 1.08B | 82.97% |
| Dec 31, 2015 | 591.80M | 17.51% |
| Dec 31, 2014 | 503.60M | 87.28% |
| Dec 31, 2013 | 268.90M | 9.58% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celldex Therapeutics | 1.75B |
| Recursion Pharmaceuticals | 1.73B |
| Galapagos NV | 1.73B |
| Fortrea Holdings | 1.72B |
| Clover Health Investments | 1.68B |
| GoodRx Holdings | 1.66B |
| Immunocore Holdings | 1.62B |
| 10x Genomics | 1.61B |